Hector DeLuca may be retiring as chairman of the biochemistry department, but the man who brought the University of Wisconsin millions in royalties will continue to do what he does best.
DeLuca will remain on the faculty as a researcher, studying the healing properties of vitamin D compounds. DeLuca, 74, said he had to scale back because he has been undergoing chemotherapy for a treatable form of lymphoma.